SURVIVAL OF PROSTATE CANCER PATIENTS WITH COMBINATION HORMONAL-RADIOTHERAPY BETTER THAN HORMONAL THERAPY
نویسندگان
چکیده
منابع مشابه
Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art
Androgen-deprivation therapy (ADT) is used routinely in combination with definitive external beam radiation therapy (EBRT) in patients with high-risk clinically localized or locally advanced disease. The combined treatment (ADT-EBRT) also seems to play a significant role in improving treatment results in the intermediate-risk group of prostate cancer patients. On the other hand, there is a grow...
متن کاملLocal prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
BACKGROUND The outcome of patients after radiotherapy (RT) for localized prostate cancer in case of prostate-specific antigen (PSA) progression during primary hormonal therapy (HT) is not well known. METHODS A group of 27 patients presenting with PSA progression during primary HT for local prostate cancer RT was identified among patients who were treated in the years 2000-2004 either using ex...
متن کاملHormonal Milieu of Prostate Cancer
Androgens and the androgen receptor have been implicated in a number of human diseases and conditions, most notably prostate cancer. [1] Huggins and Hodges in 1941 demonstrated that bilateral orchiectomy or estrogen treatment is an effective treatment for prostate cancer.[2] Based upon their findings, androgen deprivation therapy (ADT) has remained the main therapeutic option for patients with ...
متن کاملNeoadjuvant hormonal therapy in prostate cancer - impact of PSA level before radiotherapy.
PURPOSE To retrospectively investigate the impact of prostate specific antigen (PSA) level after neoadjuvant androgen- deprivation therapy (ADT) on biochemical relapse-free survival in patients with prostate cancer who received radical radiotherapy (RT). METHODS Between March 2003 and March 2008, 128 men with localized prostate cancer underwent neoadjuvant ADT for 4-6 months followed by radic...
متن کاملCardiovascular risk during hormonal treatment in patients with prostate cancer
The objective of this review is to provide information on cardiovascular risk following androgen-deprivation therapy (ADT) in prostate cancer patients and to suggest potential prevention and management strategies. Androgen deprivation therapy can cause peripheral insulin resistance, increase fat mass and low-density lipoprotein cholesterol, and induce type 2 diabetes. While recent studies have ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indonesian Journal of Urology
سال: 2020
ISSN: 0853-442X,2355-1402
DOI: 10.32421/juri.v27i2.583